-+ 0.00%
-+ 0.00%
-+ 0.00%

PURETECH HEALTH - PHASE 1B TRIAL OF LYT-200 IN RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA TOPLINE EFFICACY DATA EXPECTED IN Q4 2025

Reuters·11/03/2025 14:09:13

Please log in to view news